Cargando…
Meeting the Demand for Unrelated Donors in the Midst of the COVID-19 Pandemic: Rapid Adaptations by the National Marrow Donor Program and Its Network Partners Ensured a Safe Supply of Donor Products
The impact of the coronavirus disease 2019 (COVID-19) pandemic on hematopoietic cell transplant (HCT) donor registries and transplant center (TC) practices is underreported. This article reports on the National Marrow Donor Program (NMDP) Be The Match Registry and its coordinating the provision of u...
Autores principales: | Auletta, Jeffery J., Novakovich, Jen L., Stritesky, Gretta L., Newman, Jeni, Fridy-Chesser, Sade T., Hailperin, Karl, Devine, Steven M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834500/ https://www.ncbi.nlm.nih.gov/pubmed/33830022 http://dx.doi.org/10.1016/j.jtct.2020.10.014 |
Ejemplares similares
-
Ongoing Risk of Unrelated Donors Testing Positive for COVID-19 Following Medical Clearance and Impact on Operations: A Report from the National Marrow Donor Program
por: Stefanski, Heather E., et al.
Publicado: (2023) -
Neither COVID-19, Nor Cryopreservation, Prevented Allogeneic Product Infusion: A Report from the National Marrow Donor Program
por: Stefanski, Heather E., et al.
Publicado: (2021) -
Recruiting unrelated donors for the National Marrow Donor Program.
por: Yanke, D. R.
Publicado: (1990) -
Neither COVID-19, nor cryopreservation, prevented allogeneic product infusion: A report from the National Marrow Donor Program
por: Farhadfar, Nosha, et al.
Publicado: (2022) -
COVID19 seroconversion in an unrelated stem cell donor
por: Maakaron, Joseph E., et al.
Publicado: (2020)